Attention Investors : Prevent Unauthorized Transactions in your Trading / demat account -->Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. Update your Mobile Number & e mail id with your Broker / Depository Participant. Receive alerts on your Registered Mobile for all Transactions / debit and other important transactions in your Trading / demat account directly from Exchanges & CDSL on the same day. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month......... Issued in the interest of investors. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. SCORES - Filing compliant on SCORES – Easy & quick    a. Register on SCORES portal.    b. Mandatory details for filing complaints on SCORES : Name, PAN, Address, Mobile Number, Email ID.    c. Benefits : Effective communication . Speedy redressal of the grievances Website : https://scores.sebi.gov.in/ Head Office / ARN Desk Backoffice Employee Sub-Broker/Sale Manager Branch Client Quotes NAV Insurance NAV

mutual funds  Mutual Funds MF Schemes Fund Profile Scheme Profile Daily NAV Historical NAV MF Synopsis Biggest Scheme Fund Performance Least Volatile Schemes Dividend Announcement MF Trends Dividend Details MF Activities Top 10 Holdings What's In & Out Scheme Comparison Portfolio Comparison MF Buzz MF News New Fund Offer Fund Manager's Interview MF Tools Returns Calculator SIP Calculator Knowledge Center Form Download Tax Implication Knowledge Center PAN Circulation Equities | Mutual Funds | Commodities | Derivatives | IPO | Insurance Products & Services    >   Mutual Funds   >   Snap Shot Enter a Single character of a Scheme : 02 Sep 2025 | 00:09 IST Nippon India Pharma Fund (G) All Summary NAV Details Latest Payouts Investment Details Performance Asset Allocation Holdings Summary Info Fund Name : Nippon India Mutual Fund Scheme Name : Nippon India Pharma Fund (G) AMC : Nippon India Mutual Fund Type : OPEN Category : Equity - Pharma Launch Date : 10-May-04 Fund Manager : Sailesh Raj Bhan Net Assets:(Rs. cr) 8736.57   1Month 3Month 6Month 1Year 3Year 5Year Since Inception NAV Details NAV Date : 01-Sep-25 NAV [Rs]: 509.16 Buy/Resale Price [Rs] : 0.00 Sell/Repurchase Price [Rs] : 0.00 Max Entry Load % : 0.00 Max Exit Load % : 0.00 Latest Payouts   Dividends Bonus Quantum of Dividend % NA NA Date NA NA Investment Details Tax benefits :   Min. Investment(Rs.) : 5000 Increm.Investment(Rs.) : 1000 Performance(%)   1 Week [%] 1 Month [%] 3 Month [%] 6 Month [%] 1 Year [%] 3 Year [%] 5 Year [%] Since INC [%] Scheme Returns -2.65 -5.14 0.42 12.45 -0.80 22.88 18.00 20.31 Category Avg -2.63 -4.17 2.45 13.50 1.66 24.35 18.65 15.91 Category Best -2.10 -2.52 6.24 18.28 12.38 29.31 21.80 33.87 Category Worst -3.08 -5.22 -4.35 8.23 -12.80 19.97 13.93 -3.67 Statistical Ratios What is Beta ? Beta is a measure of the volatility of the portfolio to that of the index. In simple words it shows the movement of the portfolio in comparison. The Higher the Beta, higher the volatility of the scheme to the index. If its greater than1 , then the portfolio is highly volatile to the movemnts in the index. If the beta is lesser than 1 , then scheme is less volatile to the index and beta which is close to 1 implies that the scheme is closely following the index. Beta [%] SD [%] Sharpe Ratio [%] Jensons Alpha [%] ER [%] 0.7275 4.2193 1.2140 12.8304 0.0322 Holdings Date :31-Jul-25 Company Name % Hold Sun Pharma.Inds. 12.22 Divi's Lab. 7.55 Lupin 5.93 Cipla 5.69 Dr Reddy's Labs 5.69 Apollo Hospitals 5.57 Medplus Health 3.86 Vijaya Diagnost. 3.55 Glaxosmi. Pharma 3.31 Gland Pharma 3.12 Ajanta Pharma 3.02 Abbott India 2.70 Thyrocare Tech. 2.63 Dr Lal Pathlabs 2.38 Sai Life 2.36 Narayana Hrudaya 2.26 Mankind Pharma 2.23 Zydus Lifesci. 2.22 Aurobindo Pharma 2.22 J B Chemicals & 2.02 Pfizer 1.89 Alkem Lab 1.86 Biocon 1.77 Sanofi India 1.54 Suraksha Diagno. 1.34 Ipca Labs. 1.33 Torrent Pharma. 1.30 Sanofi Consumer 1.20 Fortis Health. 1.08 Syngene Intl. 1.05 Anthem Bioscienc 0.92 Akums Drugs 0.90 Emcure Pharma 0.76 Indoco Remedies 0.67 Astrazeneca Phar 0.66 Orchid Pharma 0.42 Concord Biotech 0.23 TREPS 0.26 Net CA & Others 0.29 C C I 0.00 Asset Allocation Bar Chart Pie Chart 3D Bar Chart 3D Pie Chart              SEBI Common Reg. No. INZ000206338          MAPIN NO:10014845        CDSL : IN-DP-CDSL-291-2005 MERCHANT BANKING REGISTRATION NO : NM000011575 Terms of the Site   I   Privacy Policy   I  Disclaimer   I  Broker Norms   I  Attention and Advisory for Investors   I  Investor Relations   I  Investor Charter   I  Site Map   I  Payment Gateway   I  Circular   I  Upfront Margin   I  Pricing   I  Investor Complaints   I  Depository Participant   I  Investor Complaints for DP   I  CDSL E-Voting   I  Maintenance of Website   I   Details of authorized persons   I   SMART ODR   I   Bank Details   I   View Client Collateral Details   I   Online KYC Closure INTERNAL CONTROL POLICY  I  AML POLICY  I  RMS POLICY  I  POLICIES & PROCEDURES  I  CLIENT ACCEPTANCE POLICY   I   CLIENT REGISTRATION FORM KYC Form Mandatory Document   I   DOCUMENTS IN VERNACULAR LANGUAGES BSE  I  NSE  I  CDSL  I  SEBI  I  MCX  I  NCDEX © 2010 SHARE MART. All rights reserved Designed, Developed and Content provided by CMOTS Infotech ( ISO 9001:2015 certified )